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Abstract
The cellular response elicited by an environmental cue typically varies with the strength of the stimulus. For example, in the
yeast Saccharomyces cerevisiae, the concentration of mating pheromone determines whether cells undergo vegetative
growth, chemotropic growth, or mating. This implies that the signaling pathways responsible for detecting the stimulus and
initiating a response must transmit quantitative information about the intensity of the signal. Our previous experimental
results suggest that yeast encode pheromone concentration as the duration of the transmitted signal. Here we use
mathematical modeling to analyze possible biochemical mechanisms for performing this ‘‘dose-to-duration’’ conversion. We
demonstrate that modulation of signal duration increases the range of stimulus concentrations for which dose-dependent
responses are possible; this increased dynamic range produces the counterintuitive result of ‘‘signaling beyond saturation’’
in which dose-dependent responses are still possible after apparent saturation of the receptors. We propose a mechanism
for dose-to-duration encoding in the yeast pheromone pathway that is consistent with current experimental observations.
Most previous investigations of information processing by signaling pathways have focused on amplitude encoding
without considering temporal aspects of signal transduction. Here we demonstrate that dose-to-duration encoding
provides cells with an alternative mechanism for processing and transmitting quantitative information about their
surrounding environment. The ability of signaling pathways to convert stimulus strength into signal duration results directly
from the nonlinear nature of these systems and emphasizes the importance of considering the dynamic properties of
signaling pathways when characterizing their behavior. Understanding how signaling pathways encode and transmit
quantitative information about the external environment will not only deepen our understanding of these systems but also
provide insight into how to reestablish proper function of pathways that have become dysregulated by disease.
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Introduction
Many substances, such as hormones, neurotransmitters and a
variety of pharmaceuticals, affect cellular behavior by binding to
membrane receptors and activating intracellular signaling pathways.
Thesepathways transmit information fromthe plasmamembrane to
selected cellular components to generate an appropriate response to
the environmental cue. However, signaling networks are not simply
passive relay systems, but actively modulate the transmitted signals.
For example, cross inhibition is used to avoid spurious crosstalk
between pathways. Similarly, negative feedback allows pathways to
adapt or desensitize to persistent stimuli [1,2]. In many cases, the
nature of the response depends on the dose of the stimulus. Thus, in
addition to relaying qualitative information (e.g. the presence or
absence of a stimulus), signaling pathways must also transmit
quantitative information about the intensity of the stimulus.
Many signaling pathways consist of a cell surface receptor, G
protein transducer, and a series of protein kinases, including a
mitogen activated protein kinase (MAPK). This architecture is
widely employed in mammalian cells, but is also found in single-
cell eukaryotes such as yeast [3]. The pheromone response
pathway of the yeast Saccharomyces cerevisiae provides an instructive
example in which the elicited cellular response depends on the
concentration of the stimulus. At low pheromone levels, cells
continue vegetative growth. At intermediate concentrations, cells
develop an elongated morphology and in the presence of a
pheromone gradient the growth is directed to the source of the
stimulus, a process known as chemotropic growth [4–7]. Finally, at
high pheromone concentrations cells initiate a mating program
that eventually leads to growth arrest and the development of
mating projections (for a review see [3]). Therefore, for yeast to
make the correct developmental decision, quantitative information
about the pheromone concentration must be reliably transmitted
to the appropriate cellular components. Here we use mathematical
modeling to investigate the different ways this information can be
transferred. The results of this analysis taken together with our
recently published data demonstrate that the pheromone pathway
uses a strategy in which the agonist dose is encoded as the duration
of the signal. Because the yeast pheromone response pathway
consists of a G-protein coupled receptor and MAP kinase cascade,
the results of our investigations should have direct implications for
signal transduction in mammalian cells.
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Quantitative Information Transfer
In the simplest scenario of a linear signaling pathway subject to
a sustained stimulus (Figure 1A), quantitative information about
the dose of the stimulus can only be transmitted as the activity level
of the signaling proteins that make up the pathway. We refer to
this mode of signal transduction as ‘‘amplitude encoding’’ because
information about the stimulus is contained in the amplitude of the
propagated signal [8]. For linear pathways, the dynamic range,
(i.e., the range of stimulus levels to which the pathway can respond
in a dose-dependent manner) is limited when the activity of a
pathway component becomes saturated. Often, a downstream
component saturates before the receptor. Thus the agonist
concentration required to achieve the maximum downstream
response may be less than the concentration needed to saturate the
receptors, causing the dose-response curve of the pathway to shift
to the left of the receptor-occupancy curve (Figure 1B). Pharma-
cologists refer to this phenomenon as ‘‘amplification’’ or ‘‘receptor
reserve’’.
Signaling networks are rarely linear, however, and often include
combinations of feedback and feed-forward loops that positively
and negatively regulate pathway activity. Among other things,
these regulatory mechanisms allow signaling systems to respond
transiently (adapt) to a persistent stimulus. We show that transient
pathway activation provides the possibility of ‘‘dose-to-duration’’
encoding. That is, information about the stimulus concentration is
transduced as the duration of the propagated signal rather than
the amplitude. We demonstrate that an advantage of dose-to-
duration encoding is that it provides a mechanism for increasing
the dynamic range of signaling systems by allowing them to
respond in a dose-dependent manner even after pathway
components have become saturated, even at agonist concentra-
tions that saturate the receptor (Figure 1C).
In the following sections, we analyze dose-to-duration encoding
as a means for relaying quantitative information about the
extracellular environment and discuss simple pathway architec-
tures capable of carrying out this conversion. The key information
transfer in this strategy occurs during the transient activation of
pathway components rather than through their steady state levels
of activation [9]. Next, we present data for MAP kinase activity
that demonstrates dose-to-duration encoding is used in the
pheromone response pathway of yeast. Finally, we present a
mathematical model of the pathway based on the mechanisms
discussed here that is consistent with experimental observations.
Encoding Information as Signal Duration
Dose-to-duration encoding requires the propagated signal to act
transiently. That is, at least one component of the pathway must
return to its pre-stimulus level on a time-scale significantly shorter
than that of the physiological response. This transient activity can
result from the stimulus itself acting transiently or arise because the
pathway contains regulatory elements that convert a sustained
input into a transient output. The first case is commonly observed
in inter-cellular signaling, where the duration of pathway activity
often is regulated by the slow degradation or elimination of the
agonist (e. g., reuptake of a neurotransmitter) [10,11]. We focus on
the second case, that is, adaptive systems that possess the ability to
convert the intensity of the input signal into duration of the output
signal in the presence of a persistent stimulus. Figure 2 shows
schematically how dose-to-duration encoding works. In this
example, a fixed agonist concentration quickly activates receptors
in the plasma membrane. The steady-state level of active receptor
(input) causes the activation of a signaling module (‘‘encoder’’, grey
box) that generates a transient activation of the signaling protein
A. We use an asterisk to denote the active form of a protein (e.g.,
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Figure 1. Dose response in signaling pathways. (A) A linear
signaling pathway (L: ligand, R: receptor, A–C: signaling molecules, red
dots: phosphate groups). (B) Dose response curves for a linear pathway.
Saturation of a downstream pathway component leads to a shift of the
physiological response curve (purple) to the left of the receptor
occupancy curve (dashed black). Sensitivity at low stimulus doses is
increased but the dynamic range (gray area) is reduced. (C) Dose
response curves for a nonlinear pathway. Feedback or feed forward
regulation can extend the dynamic range of the system (purple curve)
and produce responses with an EC50 value displaced to the right of the
receptor Kd.
doi:10.1371/journal.pcbi.1000197.g001
Author Summary
Cells must be able to detect and respond to changes in their
surroundings. Often environmental cues, such as hormones
or growth factors, are received by membrane receptors that
in turn activate intracellular signaling pathways. These
pathways then transmit information about the stimulus to
the cellular components required to elicit an appropriate
response.Inmanycases,thenatureoftheresponsedepends
on the dose of the stimulus. Thus, in addition to relaying
qualitative information (e.g., the presence or absence of a
stimulus), signaling pathways must also transmit quantita-
tive information about the intensity of the stimulus. Here we
introduce ‘‘dose-to-duration’’ encoding as an effective
strategy for relaying such information. We demonstrate that
by providing a mechanism for overcoming saturation
effects, modulation of signal duration increases the range
of stimulus concentrations for which dose-dependent
responses are possible. This increased dynamic range
produces the counterintuitive result of ‘‘signaling beyond
saturation’’ in which dose-dependent responses are still
possible after apparent saturation of the receptors. Finally,
we demonstrate that dose-to-duration encoding is used in
the yeast mating response pathway and presents a simple
mechanism that can account for current experimental
observations.
Dose-to-Duration Encoding
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amplitude but dose-dependent duration (A* in Figure 2). At each
stimulus dose, the amplitude of A* rapidly saturates, but
information about the level of receptor occupancy is preserved
in the duration of the A* signal. Mechanisms capable of such dose-
duration transformations are the subject of the next section.
Figure 2 shows two possible scenarios for how A* activates its
downstream targets. In the first scenario, species B is slowly
activated by A*. This causes the activity of B (B*) to increase
during the entire period of A’s transient activation. If the kinetics
for the deactivation of B also are slow, B activity remains elevated
for a significant amount of time after the A* has returned to its
basal level. In this case B effectively works as a decoder,
transforming the duration of A activity into the amplitude of B
activity. In other words, slow kinetics makes B an integrator
capable of measuring how long the upstream signal has been on.
In the second scenario depicted in Figure 2, species C has fast
activation and deactivation kinetics. As a result, the C*
concentration closely mimics the behavior of A*, reaching a
quasi-equilibrium level soon after the signal is received and rapidly
returning to pre-stimulation levels once A activity ceases. In this
case, quantitative information about the stimulus is preserved even
when C* is saturated because it is encoded as signal duration. We
note that dose-to-duration encoding does not place restrictions on
what types of responses a cell can initiate. For example, positive
feedback acting downstream of either components B or C can be
used to convert transient pathway activation into a permanent
developmental switch [12].
Simple Architectures That Function as Duration Encoders
In this section we discuss mechanisms that can achieve dose-to-
duration encoding. As previously mentioned, we are focusing on
cases involving a sustained input, and therefore need to consider
systems capable of adaptation or desensitization. In order to work as
a dose-to-duration transducer, the duration of the output has to
increase with the concentration of the stimulus. As we illustrate
below, this is not a general property of adaptive systems. Figure 3
shows a number of architectures capable of performing the dose-to-
duration transformation. The two pathway architectures depicted in
Figure 3A consist of incoherent feed-forward loops [13] in which the
upstream stimulus activates both a positive and negative regulator of
the signaling protein K. For the system to show transient activity,
negative regulation must occur on a slower time scale than the
activation rate of K. As shown in the figure, this can be achieved if
the negative regulation is mediated by an intermediate species X.
This species can operate either by inhibiting activation of K by KK
or by promoting deactivation of K. This type of architecture occurs
in ERK signaling networks in which agonists, such as epidermal
growth factor, causes transient extracellular signal-regulated kinase
(ERK) activation by triggering rapid Ras activation followed by slow
recruitmentofitsnegativeregulator,RasGTP-aseregulatingprotein
(Ras-GAP), to the membrane [14].
Figure 3B shows two simple pathway architectures involving
negative feedback loops that can exhibit adaptive behavior. In
these examples, the signaling molecule activates its own negative
regulator. In the first case, the negative regulator X increases the
deactivation rate of K and in the second case X decreases the
activation rate of K. Both strategies produce qualitatively similar
behavior. Similar to the case of feed forward regulation, adaptive
behavior in these systems requires the negative feedback to operate
on a slower time scale than that of activation of K. This type of
architecture plays a role in the regulation of ERK signaling by the
enzymatic activation of members of the MAPK phosphatase group
(MKP’s) [15–17], and in the regulation of cytokine signaling by the
induction of suppressor of cytokine signaling (SOCS) proteins [18].
We focus primarily on the negative feedback system depicted by
the left diagram in Figure 3B, but the results that follow easily
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Figure 2. Dose-to-duration encoding. The receptor occupancy
level is proportional to the ligand concentration. An encoder transforms
receptor occupancy (RL) into the duration of protein A activity (A*). A*
activates two downstream proteins, B and C. Because of its slow
activation kinetics, B acts as an integrator transforming the duration of
A activity into the amplitude of B activity (B*). Protein C has fast kinetics
and therefore its activity level (C*) follows A* and information continues
to be transmitted as signal duration.
doi:10.1371/journal.pcbi.1000197.g002
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Figure 3. Pathway architectures that convert stimulus dose to
signal duration. (A) Feed-forward and (B) negative feedback
encoding modules (KK: Kinase-Kinase, K: Kinase, X: Phosphatase).
Shown are cases of negative regulation operating by inhibiting
activation (left diagrams) or promoting deactivation (right diagrams).
doi:10.1371/journal.pcbi.1000197.g003
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this model are given in the Methods. To understand how this
system performs the dose-to-duration transformation, it is helpful
to consider the steady-state response curve of K as a function of
the activity of the upstream component KK in the absence and
presence of the negative regulator X. In Figure 4A, the left curve
corresponds to the case in which X has been deleted. When
present, the effect of the negative regulator X is to shift the signal-
response curve to higher active KK concentrations. Accordingly,
the right curve shown in Figure 4A corresponds to the case in
which X is maximally activated.
The responseofthe system now can be understood byconsidering
how the signal-response curve shifts in time (Figure 4B). This
approach is valid because the requirement of slow negative feedback
implies that the K and K* concentrations are in quasi-equilibrium
with respect to the current X* concentration. Figure 4C (left) shows
time series for an example in which the level of KK* is given by the
blue vertical line in Figure 4B. Upon activation, KK* quickly drives
the level of K activity to the steady-state value expected in the
absence of the negative regulator X, which for this example
corresponds to full activation. Subsequent to the initial rapid rise of
K*,theactivationanddeactivationratesroughlybalance(Figure4C,
right) and the relative ratios of K and K* remain in a quasi-
equilibrium determined by the current level of X*. As the level of X*
slowly increases, the signal-response curve gradually shifts to the
right (Figure 4B), and eventually, the EC50for K activation moves
beyond the available concentration of KK. At this point the
concentration of X* is such that the stimulus cannot counteract the
level of negative regulation and K* activity returns to near basal
levels (Figure 4C, left).
The two properties required for the dose-to-duration transfor-
mation are that (i) the activation rate of K is proportional to the
stimulus concentration (KK* concentration in the model under
consideration) and (ii) the kinetics of the negative regulator are
slow. It is also important that the negative regulator induces a
reversible change in K rather than on irreversible change, such as
degradation or irreversible desensitization. Under these condi-
tions, by slowly increasing the deactivation rate of K*, the system is
Figure 4. Dose-to-duration encoding by negative feedback. The units of concentration are arbitrary and time is measured in minutes. The
responses are normalized to the total concentration of the respective proteins. (A) Response curves for species K shown in the absence of the
negative regulator X (left curve) and in the presence of maximal X activity (right curve). (B) Displacement of the response curve during a signaling
event. Blue curve: KK* level used to generate the curves in (C). (C) Time profiles of [K*] (red curve) and [X*] (green curve, left panel) and the activation
rate of K (red curve) and deactivation rate of K* (dashed blue curve, right). Note that after an initial spike in the activation rate, the two rates roughly
equalize satisfying the quasi-equilibrium condition. The system adapts when the activation rate can no longer increase and compensate for the
increasing X activity. (D) An expanded version of the response curves shown in (A) indicating the four possible operational regimes. (E) Time courses
of K activity illustrating the four operational regimes. (F) Signal duration (defined as time between half maxima) vs. KK* concentration. Regimes I and
II are shown. (G) Same as (E) except the different regimes are now shown on the same graph.
doi:10.1371/journal.pcbi.1000197.g004
Dose-to-Duration Encoding
PLoS Computational Biology | www.ploscompbiol.org 4 October 2008 | Volume 4 | Issue 10 | e1000197actually ‘‘measuring’’ the activation rate of K rather than the K*
concentration. The readout is the time necessary to produce
enough X* to counteract the stimulated activation rate of K and
bring K* back to basal levels. Importantly, this approach can
potentially be used to measure stimulus concentrations much
higher than those that would saturate pathway activity in the
absence of negative feedback. In other words, by exploiting the time-
dependent properties of the system, signaling pathways can increase their
dynamic range.
The dose-to-duration transformation described above occurs
most efficiently when the activity level of the signaling component
involved in the transformation is saturated. More generally, there
is a repertoire of four operational regimes available to the adaptive
system. These are summarized in Figure 4D and 4E. Figure 4D
again shows the steady state response curves in the absence (left)
and presence (right) of the negative regulator. In this figure, the
graph has been expanded for illustrative purposes. The four
shaded regions correspond to the different operational regimes.
The first regime corresponds to low stimulus concentrations.
When the stimulus strength increases within this regime, the
response of the system consists of transient peaks of increasing
amplitude but roughly the same duration (Figure 4E, left). For
each stimulus, the peak amplitude can be approximately
determined by the signal-response curve in the absence of negative
regulation. Increased upstream K activity increases the rate at
which X is activated, and hence only a relatively weak dependence
of the signal duration on the stimulus dose is observed.
Regime II arises when the stimulusstrength issufficient tosaturate
K activity. This is the regime in which the dose-to-duration
transformation occurs (Figure 4E, center). Figure 4F presents the
relationship between signal duration (defined as time between half-
maxima) and stimulus concentration in Regimes I and II. In Regime
III, the stimulus level is high enough so that the negative regulator is
no longer able to counteract the induced activation rate of K, even
when X is maximally activated. In this regime the system begins to
lose its ability to adapt (Figure 4E, right). If the stimulus level
increases even further, the system operates in Regime IV and
adaptation no longer occurs (Figure 4E, right). In this regime, a
sustained inputproducesa sustainedoutput.Therefore,thispathway
architecture is capable of acting as a switch; at low stimulus dose the
response is transient, whereas at high levels the response becomes
sustained. To illustrate how the transition between these regimes
occurs, Figure 4G shows characteristic time series from each regime
on the same graph. Physiological conditions and kinetic properties of
signaling pathways may constrain some systems to operate in a
subset of the theoretically possible regimes.
The minimalistic systems described here are intended to
illustrate some of the mechanisms available to signaling networks
for producing dose-to-duration encoding. Although very simple,
they are useful for understanding the behavior of more complex
architectures. The addition of more pathway components would
not change the underlying operating principles of dose-to-duration
encoding. In fact, additional components can be used to generate
more robust responses and provide more opportunities to fine-tune
the input-output relations of the pathway.
Dynamic Regulation of the Receptor Allows Signaling
beyond Saturation
When operated in Regime II, the temporal profile of K*
resembles a square pulse (Figure 4C). This is because the signal-
response characteristics of the system in the absence of the
negative regulator were taken to be switch-like. Therefore, it is
important to study how the dose-to-duration transformation is
affected when this assumption is relaxed. We start by observing
that the switch-like signal-response curves result from the small
values of the Michaelis constants used in the reaction rates (k1m,
k2m, and k3m in Equation1), which means that the reaction rates
saturate at low substrate levels. In the opposite extreme, the
activation rates operate far from saturation. In this case, the
catalytic reactions can be described in terms of mass action
kinetics. For the system to efficiently adapt, a relatively steep dose-
response curve is still required. This can be achieved by
manipulating the parameters involved in the negative regulation.
For such cases, the system’s response to a sustained stimulus is no
longer a square pulse, but shows a more gradual decay in time (cf.
Figure 5C, middle). However, as we show next, the length of time
required for the signal to decline below a given threshold still
depends on the strength of the stimulus, and therefore the stimulus
concentration can still be encoded as signal duration.
The scenario discussed above is of particular interest because it
applies to a situation in which the negative feedback loop acts at
the level of the receptor. Figure 5A shows a schematic diagram of a
model in which the ligand-bound receptor activates a negative
pathway regulator X. The protein X inhibits the pathway by
modifying the ligand-bound receptor (phosphorylation in this
example) and decreasing its affinity for the ligand (Figure 5A).
Equations 2–4 of the Methods provide a mathematical description
of this model. Figure 5B shows the steady-state receptor occupancy
curves in the absence and presence of the negative regulator X.
Temporal responses of the ligated receptor concentration for the
four operational regimes are shown in Figure 5C. Note that while
these time series do not have square pulse shapes, dose-to-duration
encoding is still possible, because higher ligand levels cause active
receptors to persist for longer times (Figure 5C, middle).
Furthermore, a square-pulse activity profile is easily generated if
the pathway contains a downstream component with switch-like
signal-response characteristics. As shown in Figure 5D, the
pathway component B measures how long receptor occupancy
remains above its activation threshold, thereby transforming the
time series for receptor occupancy into a square-pulse of B activity.
An important consequence of this pathway architecture is that it
allows for ‘‘signaling beyond saturation’’. That is, the system
responds in a dose-dependent manner to ligand concentrations
higher than required to saturate the receptor (Figure 1C). In other
words, the dissociation constant of the receptor can be dynamically
modulated and exploited to expand the dynamic range of the
signaling pathway.
Dose-to-Duration Encoding in the Yeast Pheromone
Pathway
The mating response pathway of yeast mediates the organism’s
response to pheromone secreted into the medium by cells of the
appropriate mating type. When bound with pheromone, a specific
G-protein coupled receptor activates its cognate G protein causing
the dissociation of the a and bc subunits. The bc complex then
recruits the scaffold protein Ste5 to the membrane, which in turn
recruits and activates a signaling cascade composed of Ste20
(MAP4K), Ste11 (MAP3K), Ste7 (MAP2K), and the MAP kinases
Fus3 and Kss1 (Figure 6A, for a review see [3]). The developmental
response initiated by yeast depends critically on the pheromone
concentration. In the presence of very low levels or no pheromone,
cells continue to grow and divide normally. At intermediate levels of
pheromone, the cells become elongated and are capable of
chemotropic growth towards a pheromone gradient. High levels of
pheromone produce a bona fide mating response, involving cell
division arrest and the emergence of mating projections [3,5,6]. We
recently published an experimental study demonstrating that the
scaffold protein Ste5 slows the activation rate of the MAP kinase
Dose-to-Duration Encoding
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from chemotropic growth to mating [7]. In this section we present a
mathematicalanalysisofthetemporalprofilesofMAPkinaseactivity
measured as a part of our previous investigation. Our analysis
suggests that the mating response pathway is using dose-to-duration
encoding to relay information about the extracellular pheromone
concentration.
Figure 6B shows time course data for active (dually-phosphor-
ylated ) Fus3 and Kss1 as measured by immunoblotting for wild
type cells in response to different pheromone concentrations (see
[7] and methods for details of the experimental methods). The
transition from chemotropic growth to mating occurs between 3
and 10 mM, where there is a large increase in Fus3 activity [7].
Note the qualitative similarity between the experimental results
and the graphs in Figure 2 (compare pp-Fus3 to B* and pp-Kss1 to
C*). The roughly dose-independent rate (slope) for Fus3
phosphorylation suggests that its activation rate is saturated. This
behavior is consistent with the level of upstream kinase activity
being independent of the pheromone dose, whereas the duration
of this activity is dose-dependent. On the other hand Kss1 shows
fast kinetics. Note that for high pheromone concentrations
(10 mM), Kss1 seems to undergo two stages of phosphorylation
with a second increase in phosphorylation starting around 30 min
after exposure. If we disregard this second increase in Kss1 activity
(see Discussion), then by virtue of its fast kinetics, Kss1
phosphorylation mirrors the upstream signal dynamics. Further-
more, it appears from the data that for the doses measured, Kss1
operates in Regimes I and II (and perhaps III) of Figure 4. These
observations when combined with the very good correlation
between the duration of Kss1 and Fus3 activity, suggest that Fus3
and Kss1 phosphorylation are driven by an upstream signal in
which the pheromone dose has been converted to signal duration.
To test the idea of dose-to-duration encoding, we sought to
establish a single upstream input profile capable of reproducing
the experimental results for both Kss1 and Fus3. Specifically, we
looked for a signal profile s(t) that when used as input to the
equations for Fus3 activation (Equation 7) and Kss1 activation
(Equation 8) generates the Fus3 and Kss1 activity time series
shown in the left and right panels, respectively, of Figure 6B. The
analysis produced the input signals and MAP kinase profiles shown
in Figure 6C and 6D, respectively. The excellent agreement
between the experimental data and model output provides strong
evidence in support of dose-to-duration encoding by the
pheromone response pathway.
In principle, any of the encoding mechanisms discussed in the
previous sections can produce temporal profiles similar to
Figure 6C (see Figures 4 and 5), and there are several potential
candidates for the negative feedback loop that mediates the dose-
to-duration transformation in the mating pathway. These include
transcriptional induction of either the RGS protein Sst2, which
increases the rate at which the Ga subunit hydrolyzes GTP [19],
or the protease Bar1, which degrades pheromone [20,21]. Note
Figure 5. Feedback regulation of receptor affinity. The units are the same as in Figure 4. (A) The active receptor activates species X, which in
turn phosphorylates the ligand-bound receptor, decreasing the affinity of the receptor for the ligand. (B) Receptor occupancy curves in the absence
and presence of active X. (C) Time courses for the ligand-bound receptor corresponding to the four operational regimes shown in Figure 4. (D) The
temporal profiles from Regime II in (C) are used as input signals for species B. The switch-like response of B converts the input signal into a square-
pulse output signal.
doi:10.1371/journal.pcbi.1000197.g005
Dose-to-Duration Encoding
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pathway deactivation occurs within 30 min at low pheromone
concentrations, it is likely that feedback loops involving protein
modifications also play a role in the dose-to-duration transforma-
tion. Furthermore, because the MAP kinases respond in a dose-
dependent manner at pheromone concentrations significantly
higher than the reported receptor Kd value of 5–15 nM [22,23], it
is plausible that dose-to-duration encoding involves feedback
regulation of the receptor. This is not the only possibility and any
target of feedback regulation at the level of the MAP2K Ste7 or
above would work equally well (see Discussion).
With the above considerations in mind, we developed a
mathematical model to investigate the scenario in which the
negative feedback loop acts on the receptor. Figure 7A shows a
schematic diagram of the system and the shape of the propagated
signal at each level of the pathway. The model is described by
Equations 3–5 and 7–9 of the Methods. As discussed in the
previous section, because the negative feedback acts on the
receptor, it is necessary to incorporate an intermediate step (MK
in Figure 7) to transform the propagated signal into a square-pulse.
Any of the upstream kinases (Ste20, Ste11 or Ste7) are capable of
performing this transformation. Figure 7B shows the predicted
upstream activation profile (compare with Figure 6C) and the
MAP kinase activation profiles produced by the models compared
with the experimental results. If we again disregard the second
increase in Kss1 activity at high pheromone concentrations, the
correspondence between the model results and experimental data
is striking, especially considering the simplicity of the model. We
note that this agreement does not prove the validity of the model,
but demonstrates that the mechanisms discussed above are
consistent with the experimental data. The model also provides
an important guide for future experimental work.
Discussion
It is widely accepted that signaling pathways are capable of
transmitting quantitative information about their surrounding
environment. While the importance of transient versus sustained
signaling has been recognized for some time [24–26], most
previous investigations have focused on information transfer using
amplitude encoding without considering the temporal aspects of
signal transduction [8,9]. Here we demonstrate that dose-to-
duration encoding provides cells with an alternative mechanism
for processing and transmitting quantitative information about
their surrounding environment. The ability of signaling pathways
to convert stimulus strength into signal duration results directly
from the nonlinear nature of these systems and emphasizes the
importance of considering the dynamic properties of signaling
pathways when characterizing their behavior. Taken together, our
computational and experimental results suggest that dose-to-
duration encoding occurs in the pheromone response pathway of
yeast and underlies the developmental switch from chemotropic
growth to mating.
One important advantage of dose-to-duration encoding is that it
has the potential to increase the dynamic range of signaling
pathways. One way this can occur is if feedback regulation
allosterically modifies the receptor’s affinity for the ligand.
Dynamically regulating the Kd of the receptor has the interesting
effect of shifting the EC50 of the cellular response to the right of the
receptor occupancy curve (Figure 1C). Depending on the response
of downstream components, the dose-response curve for the
system is not only shifted but also stretched. This highlights the
important point that receptor occupancy curves are potentially
time-dependent quantities and need to be interpreted with care.
Interestingly, Kd values determined in vitro or in reconstituted
systems usually differ from those obtained in vivo, and this
discrepancy is often attributed to an abnormal conformation of the
receptor in the artificial environment. The analysis presented here
suggests that even when there is correspondence between the
microenvironment of an in vitro experiment and the macroenvir-
onment of a cell culture, the results of ligand binding assays might
differ due to dynamic regulation of the receptor in vivo. For
example, this could happen if a downstream element of the
signaling pathway has been disrupted in the in vitro experiment,
thereby breaking the negative feedback loop. Interactions between
receptors, in particular G-protein coupled receptors (GPCRs), and
cytosolic proteins have been shown to affect receptor-ligand
affinity [27]. Most GPCR’s are known to undergo biochemical
Figure 6. The yeast pheromone response pathway. (A) Schematic diagram of the pathway. (B) Experimentally obtained time series for the
dually-phosphorylated (active) forms of the MAP kinases Fus3 and Kss1 normalized to the maximum response. The different colored data points
correspond to different pheromone concentrations. (C) Proposed upstream Ste7 signals. (D) Comparison of experimental data (circles) and model
output (curves) for time courses of Fus3 and Kss1 activity. The model results were generated using the Ste7 signals shown in (C) as input.
doi:10.1371/journal.pcbi.1000197.g006
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number of signaling proteins, including G proteins, arrestins,
kinases, RGS proteins, and to form oligomers, all of which could
affect affinity for the ligand. Therefore dynamic regulation of a
receptor as a mechanism for dose-to-duration encoding seems
quite plausible.
Dose-to-duration encoding may also provide a more robust
transmission mechanism than amplitude-encoding in multilevel
networks. This is because accurate transfer of information using
amplitude encoding requires that the input-output characteristics of
the individual components be well matched [8]. Note that dose-to-
duration encoding does not have to function throughout the whole
pathway. It is likely that multiple information processing strategies
coexist at different levels (or even under different conditions) in a
single pathway. In fact, the use of multiple information processing
strategies may provide signaling networks with more flexibility when
respondingtochangingenvironmentalconditions.Anotherpotential
advantage of dose-to-duration encoding arises from the need to
prevent spurious activation of pathways that share components.
Recently we proposed ‘‘kinetic insulation’’ [28] as a strategy for
achieving pathway specificity. Kinetic insulation relies solely on the
temporal profiles of the propagated signals to ensure signal fidelity. It
requires that at least one of the pathways responds transiently.
Because signal duration is a natural strategy for pathways with
transient activity to encode information, signaling systems with
shared components are potential candidates for dose-to-duration
encoding. Consistent with these ideas, the yeast pheromone response
pathway contains several signaling proteins (e.g., Ste11 and Ste7)
that are known to also participate in the hyper-osmotic shock [29]
and filamentous growth [30,31] pathways.
Our modeling results and experimental data provide compelling
evidence for dose-to-duration encoding by the yeast pheromone
response pathway. A key question is then what is the molecular
mechanism responsible for transducing stimulus dose into signal
duration? We have demonstrated that a scenario in which
feedback regulation acts at the level of the receptor is consistent
with our experimental data for MAP kinase activity. Our
motivation for considering such a mechanism came from data
suggesting that yeast continue to respond in a dose-dependent
manner to pheromone concentrations well beyond the reported
value for the receptor dissociation constant. As we have shown, by
dynamically altering the affinity of the receptor for pheromone,
our model provides an explanation for this phenomenon of
signaling beyond saturation. Modulation of the receptor affinity in
yeast might occur by interactions with other receptors (receptor
dimers) [32], the G-protein [27], or the RGS protein Sst2 [33].
Similarly, affinity could be altered through receptor phosphory-
lation or ubiquitination [34]. GTP-dependent changes in the
pheromone receptor affinity attributed to the interaction with the
G protein have been reported [27]. Although the physiological
relevance of this effect has not been clearly established in yeast,
this is an example of a phenomenon observed for many
mammalian GPCR’s in vitro.
We note that interpreting dose-response data for the pheromone
pathway is complicated by the presence of the protease Bar1
[20,21]. In fact, a mechanism based solely on Bar1 degradation of
pheromone is in theory sufficient to achieve the dose-to-duration
transformation. However, our recent experiments performed in a
bar1D mutant show cells responding to lower pheromone doses,
but with time courses of MAPK activity that are consistent with
dose-to-duration encoding (Supplemental Data [7]). These results
argue against a mechanism involving Bar1 alone. It should be
emphasized that dose-to-duration encoding does not require the
negative feedback to act at the level of the receptor. For example,
induction of the negative regulator Sst2 [35], feedback phosphor-
ylation of an upstream pathway component [36], or receptor
endocytosis could also accomplish this transformation, although
they would not account for the observed shift in the EC50. Thus, it
is clear more work is necessary to unambiguously identify the
mechanisms responsible for information transfer in the pheromone
Figure 7. A model for dose-to-duration encoding in the pheromone response pathway. (A) Receptor affinity is feedback-regulated by
species X. The signal is converted into a square pulse by the intermediate kinase MK (e.g., Ste20, Ste11, or Ste7), which also activates the MAP kinases
Fus3 and Kss1. (B) Time courses of signal activity at different stages of the pathway: receptor occupancy (top left) and [MK*] (top right), and Fus3 and
Kss1 activity (bottom left and right, respectively).
doi:10.1371/journal.pcbi.1000197.g007
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our modeling results and experimental data offers strong evidence
in support of dose-to-duration encoding and provides a foundation
for interpreting future experimental results.
Interestingly, the combination of fast and slow kinetics exhibited
by the two MAP kinases, Kss1 and Fus3, has the potential to form
a feed-forward adaptive system. It has been demonstrated that
pheromone-induced degradation of the transcriptional activator
Ste12 requires Fus3, but not Kss1 [37]. Ste12 might also play a
role in generating the second peak of Kss1 activity observed at
high pheromone concentrations, a possibility that we are now
investigating. In the absence of pheromone, Kss1 acts as a
transcriptional repressor by forming a complex with Ste12 and the
proteins Dig1 and Dig2 (also known as Rst1/2) [38]. It is possible
that pheromone-stimulated release of Kss1 from this complex [39]
generates a second pool of Kss1 and this pool is responsible for the
second peak of activity. However, at this point we cannot rule out
alternative explanations including transcriptional induction, re-
localization, or positive feedback.
Dose-to-duration encoding is not restricted to yeast. For
example the intensity of light (number of photons) impinging on
photoreceptors in rod cells is encoded as the duration of G protein-
mediated activity of the pathway [40]. It has been shown recently
that the RGS protein RGS9 plays a particularly important role in
determining the duration of the signal [41]. Furthermore, switches
based on transient versus sustained signals, like the ones arising
from transitions between the regimes of Figure 4, have been
proposed to underlie cell fate decision process in a number of
systems [14,26,42,43]. The recent discovery that different
temporal profiles of IkB kinase (IKK) activity in the NF-kB
signaling module selectively activate different groups of target
genes, further supports the notion that dose-to-duration encoding
plays a significant regulatory role in determining cellular
responses. In this case, stimulation of murine embryonic fibroblasts
with tumor necrosis factor-a produces a short transient peak of
IKK activity whereas stimulation with polysaccharides results in a
slower and more sustained IKK response [44,45]. The fact that
each profile affects the expression of different groups of genes
illustrates how the temporal dynamics of a signaling pathway can
play a role in determining pathway specificity.
Finally, it is remarkable that the simple pathway architectures
considered here can generate such a variety of responses
depending on the strength of the stimulus (Figure 4). These
systems not only function as amplitude and dose-to-duration
encoders, but also can act as biochemical switches that transition
from transient to sustained outputs potentially generating different
physiological responses [26,42,46]. Typical signaling pathways
involve multiple levels of regulation that in general should lead to
even more complex behavior. Our results demonstrate how
quantitative measurements of the temporal patterns of pathway
activity when combined with mathematical modeling can be used
to discover the design principles upon which signaling networks
operate and decipher the code used by these systems to transmit
information.
Methods
Model Equations
In this section we describe the mathematical models used to
generate the results presented in the figures. All the differential
equations were solved using Mathematica by Wolfram Research.
The model depicted in Figure 3B (left), in which the mechanism
for pathway adaptation involves a negative feedback loop that
increases the deactivation rate of K*, is described by the following
two equations:
dK   ½ 
dt
~
k1: KK  ½  : KTOTAL{ K  ½  ðÞ
k1mz KTotal{ K  ½  ðÞ
{
k2 K  ½ 
k2mz K  ½ 
{
k3 X  ½  : K  ½ 
k3mz K  ½ 
ð1Þ
dX   ½ 
dt
~
k4: K  ½  : XTOTAL{ X  ½  ðÞ
k4mz XTOTAL{ X  ½  ðÞ
{
K5 X  ½ 
k5mz X  ½ 
ð2Þ
Where [K]Total=[K*]+[K] and XTotal=[X*]+[X]. The parame-
ter values used to generate the results shown in Figure 4 are (in
arbitrary units): k1=1,k 1m=10
22,k 2=10
22,k 2m=10
22,k 3=8,
k3m=10
22,k 4=10
24,k 4m=10
21,k 5=5 10
26,k 5m=1. The
curves in this figure correspond to s values of: 10
22,21 0
22,3
10
22,41 0
22,61 0
22 (region I), 10
21,31 0
21,51 0
21, 1, 1.5
(region II), and 6.0, 7.0, 7.5, 8.0, 8.5, 20.0 (region III+IV).
For the model in which the negative feedback acts on the
receptor, the equations are:
dR L ½ 
dt
~k1 L ½  RTOTAL{ RL ½  { RL  ½  ðÞ {k2 RL ½  {
k0 X  ½  : RL ½ 
k0mz RL ½ 
ð3Þ
dR L   ½ 
dt
~
k0 X  ½  : RL ½ 
k0mz RL ½ 
{k3 RL  ½  ð 4Þ
dX   ½ 
dt
~
k4: RL ½  z RL  ½  ðÞ : XTOTAL{ X  ½  ðÞ
k4mz XTOTAL{ X  ½  ðÞ
{
K5 X  ½ 
k5mz X  ½ 
, ð5Þ
where RTotal=[R]+[RL]+[RL*]. For simplicity, ligand release and
receptor de-phosphorylation are taken to occur in a single step. This
simplification does not affect the results provided both biochemical
steps are not rate limiting. Even if this separation of times scales does
not exist, we do not expect a more detailed model that separates
these events to produce qualitatively different behavior.
To transform the transient response in Figure 5C into a square
pulse the following equation for B* was used
dB   ½ 
dt
~
k6: RL ½  z RL  ½  ðÞ : BTOTAL{ B  ½  ðÞ
k6mz BTotal{ B  ½  ðÞ
{
k7 B  ½ 
k7mz B  ½ 
ð6Þ
The parameters used to produce the results shown in Figure 5 are
k1=1, k 2=10
22,k 3=80, k4=1 10
24,k 4m=10
21,k 5=5 10
26,
k5m=1, k 0=10, k0m=10
21,k 6=10, k6m=10
22,k 7=4,
k7m=10
22. The curves correspond to s values of: 1 10
22,2
10
22,31 0
22,51 0
22,11 0
21 (region I), 10
21,31 0
21,51 0
21,1 ,
1.5 (region II), and 6, 10, 15, 20, 50, 500 (region III+IV).
The equations used to model the kinetics of Fus3 and Kss1
activation are
d ppFus3 ½ 
dt
~
k10:s: Fus3TOTAL{ ppFus3 ½  ðÞ
k10mz Fus3TOTAL{ ppFus3 ½  ðÞ
{
k20 ppFus3 ½ 
k20mz ppFus3 ½ 
ð7Þ
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dt
~
k30:s: Kss1TOTAL{ ppKss1 ½  ðÞ
k30mz Kss1TOTAL{ ppKss1 ½  ðÞ
{
k40 ppKss1 ½ 
k40mz ppKss1 ½ 
ð8Þ
respectively, where Fus3Total=[ppFus3]+[Fus3], Kss1To-
tal=[ppKss1]+[Kss1]. The parameters used to produce the results
shown in Figure 6 are: k10=5.53 10
24,k 10m=3.75 10
22,
k20=3.25 10
24,k 20m=3 10
21,k 30=2.55 10
22,k 30m=1,
k40=2.5 10
23,k 40m=2. The input signals consist of a square
pulse of duration tpulse followed by an exponential decay (i.e.,
signal=S for time,tpulse, and signal=S e
2(time-tpulse)/l for
time.tpulse). The signal parameter for each concentration were
as follows: S=0.2, 0.25, 0.75, 0.75, 0.75, tpulse=559,2 2 9,6 9,4 9,
49, and l=(50, 50, 250, 300, 300)63600 min.
The full model depicted in Figure 7 is described by Equations
3–5 and 7–8 above, in which s has to be replaced by [MK*]. The
following equation describes the dynamics of MK*:
dM K   ½ 
dt
~
k6: RL ½  z RL  ½  ðÞ : MKTOTAL{½MK   ðÞ
k6mz MKTotal{ MK  ½  ðÞ
{
k7 MK  ½ 
k7mz MK  ½ 
ð9Þ
Here MKTotal=[MK*]+[MK]. The parameters used to produce
Figure 7 are (arbitrary units): k1=2, k 2=3 10
22,k 3=1.9 10
2,
k4=110
24,k 4m=310
22,k 5=8.5 10
28,k 5m=2.5 10
22,k 0=6.6
10
1,k 0m=5.1 10
22,k 10=4.1 10
24,k 10m=4.4 10
24,k 20=5.9
10
24,k 20m=4.6 10
21,k 30=2.8 10
22,k 30m=2.6, k40=1.15 10
23,
k40m=3.8 10
21,k 6=3.2 k6m=4.9 10
24,k 7=1.7, k7m=3.3 10
21.
Parameter Selection
As described in [47] the signaling modules presented above are
capable of producing adaptive behavior for a wide range of
parameter values. The main condition that must be met is that
activation occurs on a fast time scale as compared to the feedback
inhibition. The parameters for the examples used to illustrate
dose-to-duration encoding were selected to comply with this
requirement. The parameters for Figure 6 were tuned manually to
generate a good fit to the data. However, the number of
experimental points leaves significant leeway for the exact shape
of the decay phase of the input signal. The parameters used to
generate the curves for Figure 7 were obtained using a Monte
Carlo algorithm. The values of the rate constants associated with
ligand binding and dissociation in the absence of feedback
regulation were fixed to reflect a Kd value of 15 nM [23].
Experimental Methods
Immunoblot data for kinases Fus3 and Kss1 were obtained from
[7]. Briefly, BY4741 (MATa leu2D met15D his3D ura3D) cells were
grown using standard practices. Cell extracts (20 mg/lane) were
resolved by 12% SDS-polyacrylamide gel electrophoresis and
immunoblotting performed as described in [42]. Band intensity
was quantified by scanning densitometry using ImageJ (National
Institutes of Health).
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